Evidence map›Paper›PMID 37621676›Full record

ArticleFrontiers in oncology2023

Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome.

Jasmine M Miller-Kleinhenz, Leah Moubadder, Kirsten M Beyer, Yuhong Zhou, Anne H Gaglioti, Lindsay J Collin, Jazib Gohar, Whitney Do, Karen Conneely, Uma Krishnamurti and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Experiences of Discrimination and DNA Methylation Among Black Nulliparous Women.Journal of racial and ethnic health disparities · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Living in historically redlined neighborhoods and biological aging among older adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Jasmine M Miller-KleinhenzDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Leah MoubadderDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Kirsten M BeyerDivision of Epidemiology, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, WI, United States.
Yuhong ZhouDivision of Epidemiology, Institute for Health & Society, Medical College of Wisconsin, Milwaukee, WI, United States.
Anne H GagliotiNational Center for Primary Care, Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, United States.
Lindsay J CollinDepartment of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Jazib GoharDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Whitney DoDepartment of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Karen ConneelyDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States.
Uma KrishnamurtiDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Keerthi GogineniDepartment of Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
Sheryl Gabram-MendolaGeorgia Center for Oncology Research and Education, Atlanta, GA, United States.
Olivia D'AngeloDepartment of Surgery, Jackson Memorial Hospital/University of Miami Miller School of Medicine, Miami, FL, United States.
Kashari HenryDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Mylin TorresDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, United States.
Lauren E McCulloughDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Emory University · USMedical College of Wisconsin · USGraduate School USA · USHuntsman Cancer Institute · USJackson Memorial Hospital · USMorehouse School of Medicine · US

Funding

IRACDA Fellowships in Research and Science Training (FIRST)K12GM000680 · NIGMS · EMORY UNIVERSITY · PI BROWN, LOU ANN S, MCCARTY, NAEL A · 2000 to 2024
$41.2M
Racism, Residential Racial Segregation, and Breast Cancer Survival Disparities among Black, Hispanic and non-Hispanic White WomenR01CA214805 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI BEYER, KIRSTEN M · 2017 to 2021
$2.5M
NRSA Training CoreTL1TR002540 · NCATS · UNIVERSITY OF UTAH · PI FAGERLIN, ANGELA, FAIRFAX, KEKE CELESTE · 2018 to 2022
$1.6M
Investigating Socio-Structural Determinants of Health and the Tumor Epigenome to Understand the Etiology of Racial Disparities in Breast CancerR00CA267674 · NCI · UNIVERSITY OF MISSISSIPPI MED CTR · PI Jasmine Miller-Kleinhenz · 2024 to 2026
$733k
Investigating Socio-Structural Determinants of Health and the Tumor Epigenome to Understand the Etiology of Racial Disparities in Breast CancerK99CA267674 · NCI · EMORY UNIVERSITY · PI MILLER-KLEINHENZ, JASMINE · 2022 to 2023
$204k
NCATS NIH HHS TL1 TR002540NCI NIH HHS K99 CA267674NCI NIH HHS L60 CA264700NCI NIH HHS R00 CA267674NCI NIH HHS R01 CA214805NIGMS NIH HHS K12 GM000680
6 · The paper itself

Abstract

Purpose: Place-based measures of structural racism have been associated with breast cancer mortality, which may be driven, in part, by epigenetic perturbations. We examined the association between contemporary redlining, a measure of structural racism at the neighborhood level, and DNA methylation in breast tumor tissue. Methods: We identified 80 Black and White women diagnosed and treated for a first-primary breast cancer at Emory University Hospitals (2008-2017). Contemporary redlining was derived for census tracts using the Home Mortgage Disclosure Act database. Linear regression models were used to calculate the association between contemporary redlining and methylation in breast tumor tissue. We also examined epigenetic age acceleration for two different metrics, regressing β values for each cytosine-phosphate-guanine dinucleotide (CpG) site on redlining while adjusting for covariates. We employed multivariable Cox-proportional hazards models and 95% confidence intervals (CI) to estimate the association between aberrant methylation and mortality. Results: Contemporary redlining was associated with 5 CpG sites after adjustment for multiple comparisons (FDR<0.10). All genes were implicated in breast carcinogenesis, including genes related to inflammation, immune function and stress response ( Conclusion: We identified novel associations between neighborhood contemporary redlining and the breast tumor DNA methylome, suggesting that racist policies leading to inequitable social and environmental exposures, may impact the breast tumor epigenome. Additional research on the potential implications for prognosis is needed.

Indexed as

breast cancerDNA methylationepigenetic age accelerationepigenomehealth disparitiesstructural racism

Identifiers

PMID37621676
PMCPMC10446968
OpenAlexW4385689672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.